| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samira Ztaou, Marianne Amalri. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease. Neurochemistry international. vol 126. 2019-12-10. PMID:30825602. |
parkinson's disease (pd) is a neurodegenerative disorder caused by the loss of nigral dopaminergic neurons innervating the striatum, the main input structure of the basal ganglia. |
2019-12-10 |
2023-08-13 |
Not clear |
| M. Amalric, C. Baunez, A. Nieoullo. Does the blockade of excitatory amino acid transmission in the basal ganglia simply reverse reaction time deficits induced by dopamine inactivation? Behavioural pharmacology. vol 6. issue 5 And 6. 2019-11-20. PMID:11224358. |
the present study investigated the potential benefit of blocking excitatory amino acid transmission in the basal ganglia, subsequent to the inactivation of dopaminergic function of rats performing a reaction time (rt) task. |
2019-11-20 |
2023-08-12 |
rat |
| J L. Alberts, C H. Adler, M Saling, G E. Stelmac. Prehension patterns in restless legs syndrome patients. Parkinsonism & related disorders. vol 7. issue 2. 2019-11-20. PMID:11248597. |
while rls patients respond favorably to dopaminergic therapies, this study suggests that pd and rls may not share the same basal ganglia pathophysiology. |
2019-11-20 |
2023-08-12 |
human |
| Vincenzo G Fiore, Francesco Rigoli, Max-Philipp Stenner, Tino Zaehle, Frank Hirth, Hans-Jochen Heinze, Raymond J Dola. Corrigendum: Changing pattern in the basal ganglia: motor switching under reduced dopaminergic drive. Scientific reports. vol 6. 2019-11-20. PMID:27540831. |
corrigendum: changing pattern in the basal ganglia: motor switching under reduced dopaminergic drive. |
2019-11-20 |
2023-08-13 |
Not clear |
| Zade R Holloway, Timothy G Freels, Josiah F Comstock, Hunter G Nolen, Helen J Sable, Deranda B Leste. Comparing phasic dopamine dynamics in the striatum, nucleus accumbens, amygdala, and medial prefrontal cortex. Synapse (New York, N.Y.). 2019-11-20. PMID:30317673. |
midbrain dopaminergic neurons project to and modulate multiple highly interconnected modules of the basal ganglia, limbic system, and frontal cortex. |
2019-11-20 |
2023-08-13 |
mouse |
| A M Muehlmann, S L Wolfman, D P Devin. The role of neurotensin in vulnerability for self-injurious behaviour: studies in a rodent model. Journal of intellectual disability research : JIDR. vol 62. issue 12. 2019-11-15. PMID:30033601. |
abnormal dopaminergic and glutamatergic neurotransmission has been implicated, especially in relation to basal ganglia and mesocorticolimbic circuits. |
2019-11-15 |
2023-08-13 |
rat |
| Mauro Ursino, Chiara Basto. Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia. The European journal of neuroscience. vol 47. issue 12. 2019-11-04. PMID:29786160. |
parkinson's disease (pd) is a neurodegenerative disorder characterized by a progressive decline in motor functions, such as bradykinesia, caused by the pathological denervation of nigrostriatal dopaminergic neurons within the basal ganglia (bg). |
2019-11-04 |
2023-08-13 |
human |
| Marta Batllori, Marta Molero-Luis, Aida Ormazabal, Raquel Montero, Cristina Sierra, Antonia Ribes, Julio Montoya, Eduardo Ruiz-Pesini, Mar O'Callaghan, Leticia Pias, Andrés Nascimento, Francesc Palau, Judith Armstrong, Delia Yubero, Juan D Ortigoza-Escobar, Angels García-Cazorla, Rafael Artuc. Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience. Journal of inherited metabolic disease. vol 41. issue 6. 2019-11-04. PMID:29974349. |
five out of 29 cases showed predominant dopaminergic signs not attributable to basal ganglia involvement, harboring mutations in different nuclear genes. |
2019-11-04 |
2023-08-13 |
Not clear |
| Nedjeljka Ivica, Ulrike Richter, Joel Sjöbom, Ivani Brys, Martin Tamtè, Per Petersso. Changes in neuronal activity of cortico-basal ganglia-thalamic networks induced by acute dopaminergic manipulations in rats. The European journal of neuroscience. vol 47. issue 3. 2019-10-22. PMID:29250896. |
the basal ganglia are thought to be particularly sensitive to changes in dopaminergic tone, and the realization that reduced dopaminergic signaling causes pronounced motor dysfunction is the rationale behind dopamine replacement therapy in parkinson's disease. |
2019-10-22 |
2023-08-13 |
rat |
| Jin-Zhong Huang, Yi Ren, Yuan Xu, Tao Chen, Terry C Xia, Zhuo-Ri Li, Jian-Nong Zhao, Fei Hua, Shi-Ying Sheng, Ying Xi. The delta-opioid receptor and Parkinson's disease. CNS neuroscience & therapeutics. vol 24. issue 12. 2019-10-14. PMID:30076686. |
although it is known that the major characteristics of pd pathophysiology are the dysfunction of basal ganglia due to injury/loss of dopaminergic neurons in the substantia nigra pars compacta dopaminergic and exhaustion of corpus striatum dopamine, therapeutic modalities for pd are limited in clinical settings up to date. |
2019-10-14 |
2023-08-13 |
Not clear |
| Arjun Tarakad, Joohi Jimenez-Shahe. VMAT2 Inhibitors in Neuropsychiatric Disorders. CNS drugs. vol 32. issue 12. 2019-10-14. PMID:30306450. |
the basal ganglia and dopaminergic pathways play a central role in hyperkinetic movement disorders. |
2019-10-14 |
2023-08-13 |
Not clear |
| Shweta Prasad, Jitender Saini, Ravi Yadav, Pramod Kumar Pa. Motor asymmetry and neuromelanin imaging: Concordance in Parkinson's disease. Parkinsonism & related disorders. vol 53. 2019-09-13. PMID:29709506. |
the onset of motor symptoms in parkinson's disease (pd) is characteristically asymmetric and correlates with dopaminergic deficit of contralateral basal ganglia. |
2019-09-13 |
2023-08-13 |
Not clear |
| Pascale Amberge. [Parkinson disease : how to improve the voice and the quality of life]. Revue medicale suisse. vol 15. issue 656. 2019-09-02. PMID:31268258. |
parkinson disease is a progressive neurodegenerative disease affecting the basal ganglia and causing the degeneration of dopaminergic neurons. |
2019-09-02 |
2023-08-13 |
Not clear |
| Sarah C Woolle. Dopaminergic regulation of vocal-motor plasticity and performance. Current opinion in neurobiology. vol 54. 2019-08-22. PMID:30359929. |
dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species. |
2019-08-22 |
2023-08-13 |
Not clear |
| Sarah C Woolle. Dopaminergic regulation of vocal-motor plasticity and performance. Current opinion in neurobiology. vol 54. 2019-08-22. PMID:30359929. |
in songbirds, vocal learning relies on an evolutionarily specialized basal ganglia nucleus, area x, densely innervated by dopaminergic inputs from the ventral tegmental area (vta). |
2019-08-22 |
2023-08-13 |
Not clear |
| Bolton K H Chau, Huw Jarvis, Chun-Kit Law, Trevor T-J Chon. Dopamine and reward: a view from the prefrontal cortex. Behavioural pharmacology. vol 29. issue 7. 2019-08-02. PMID:30188354. |
such models should aim to define the functional interactions between the pfc and basal ganglia, through which dopaminergic neurotransmission guides reward-based behaviour. |
2019-08-02 |
2023-08-13 |
Not clear |
| Çağdaş Güdücü, Emre Eskicioğlu, Didem Öz, Adile Öniz, Raif Çakmur, Murat Özgöre. Auditory brain oscillatory responses in drug-naïve patients with Parkinson's disease. Neuroscience letters. vol 701. 2019-07-29. PMID:30826418. |
parkinson's disease (pd) is a common neurodegenerative disorder affecting the function of dopaminergic cells in basal ganglia. |
2019-07-29 |
2023-08-13 |
human |
| Wolf-Julian Neumann, Henning Schroll, Ana Luisa de Almeida Marcelino, Andreas Horn, Siobhan Ewert, Friederike Irmen, Patricia Krause, Gerd-Helge Schneider, Fred Hamker, Andrea A Küh. Functional segregation of basal ganglia pathways in Parkinson's disease. Brain : a journal of neurology. vol 141. issue 9. 2019-07-17. PMID:30084974. |
parkinson's disease is characterized by a loss of dopaminergic innervation in the basal ganglia leading to complex motor and non-motor symptoms. |
2019-07-17 |
2023-08-13 |
human |
| Wolf-Julian Neumann, Henning Schroll, Ana Luisa de Almeida Marcelino, Andreas Horn, Siobhan Ewert, Friederike Irmen, Patricia Krause, Gerd-Helge Schneider, Fred Hamker, Andrea A Küh. Functional segregation of basal ganglia pathways in Parkinson's disease. Brain : a journal of neurology. vol 141. issue 9. 2019-07-17. PMID:30084974. |
clinical symptom alleviation through dopaminergic medication and deep brain stimulation in the subthalamic nucleus likely depends on a complex interplay between converging basal ganglia pathways. |
2019-07-17 |
2023-08-13 |
human |
| Karim Johari, Matthew Walenski, Jana Reifegerste, Farzad Ashrafi, Michael T Ullma. Sex, dopamine, and hypokinesia: A study of inflectional morphology in Parkinson's disease. Neuropsychology. vol 33. issue 4. 2019-07-12. PMID:30777766. |
parkinson's disease (pd), which involves the degeneration of dopaminergic basal ganglia neurons, appears to affect language. |
2019-07-12 |
2023-08-13 |
Not clear |